UTI Healthcare Fund vs ITI Pharma and Healthcare Fund Regular compare
ITI Pharma and Healthcare Fund Regular - Growth
UTI Healthcare Fund - Regular Plan - Growth Option
Chart Comparison
Overview
Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | UTI Healthcare Fund - Regular Plan - Growth Option |
---|---|---|
Fund | ITI Pharma and Healthcare Fund Regular - Growth | UTI Healthcare Fund - Regular Plan - Growth Option |
Investment Plan | Growth | Growth |
Level of Risk | Very High | Very High |
Asset Size (Cr) | ₹217 Cr | ₹1150 Cr |
Min Investment | ₹5000 | ₹5000 |
Min SIP Invesment | ₹500 | ₹500 |
Min Addl Investment | ₹1000 | ₹1000 |
Launch Date | 08 Nov 2021 | 30 Jul 2005 |
Category | Pharma & Healthcare | Pharma & Healthcare |
Fund Type | Open Ended | Open Ended |
Benchmark | NIFTY Healthcare TRI | BSE Healthcare |
Turn Over | % | 28% |
Expense Ratio | 2.35 | 2.22 |
Manager | Rohan Korde | Kamal Gada |
ISIN Code | INF00XX01BL5 | INF789F01695 |
Exits Load | ITI Pharma & Healthcare Fund - Regular Plan - Growth charges 1.0% of sell value; if fund sold before 365 days. There are no other charges./365 | UTI Healthcare Fund - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges./365 |
Trailing Lumpsum Returns
Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | UTI Healthcare Fund - Regular Plan - Growth Option |
---|---|---|
1 Month | 3.32% | 5.44% |
6 Month | -4.43% | -0.9% |
1 Year | 16.47% | 20.88% |
3 Year | 23.74% | 26.75% |
5 Year | - | 22.01% |
SIP Return Analysis
Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | UTI Healthcare Fund - Regular Plan - Growth Option |
---|---|---|
6 Month | 4.62% | 6.95% |
1 Year | 4.08% | 10.1% |
3 Year | 22.73% | 27.46% |
5 Year | - | 20.74% |
Rolling Lumpsum Returns
Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | UTI Healthcare Fund - Regular Plan - Growth Option |
---|---|---|
1 Year | 20.48% | 11.86% |
3 Year | 18.71% | 16.19% |
5 Year | - | 14.42% |
Risk Management
Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | UTI Healthcare Fund - Regular Plan - Growth Option |
---|---|---|
Standard Deviation | 15.667% | 16.371% |
Sharp | 0.739% | 0.731% |
Beta | 0.959% | 0.958% |
Alpha | -1.413% | 0.84% |
Still Confused Which Fund To Select? Don’t worry! We’re just a call away.
Get Free Experts Guidance
Fund Managers
Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | UTI Healthcare Fund - Regular Plan - Growth Option |
---|---|---|
Name | Rohan Korde | Kamal Gada |
Total AUM | ₹4626 Cr | ₹870 Cr |
Funds Managed | 10 | 1 |
ITI Pharma and Healthcare Fund Regular - Growth | UTI Healthcare Fund - Regular Plan - Growth Option |
Market Cap
Scheme Name |
ITI Pharma and Healthcare Fund Regular - Growth |
UTI Healthcare Fund - Regular Plan - Growth Option |
---|---|---|
Others | 7.57 | 1.35 |
Mid Cap | 31.22 | 26.26 |
Small Cap | 32.03 | 43.53 |
Large Cap | 29.19 | 28.87 |
Sector Allocation
Scheme Name |
ITI Pharma and Healthcare Fund Regular - Growth |
UTI Healthcare Fund - Regular Plan - Growth Option |
---|---|---|
Others | 8.42 | 0.45 |
Healthcare | 88.76 | 98.22 |
Basic Materials | 2.08 | 1.33 |
Industrials | 0.74 | - |
Financial Services | 0 | - |
Top Comparisons
Sundaram Equity Savings Fund (Formerly Known as Principal Equity Savings Fund) - Direct Plan - Growth Option
3Y Returns14.85%
Sundaram Equity Savings Fund (Formerly Known as Principal Equity Savings Fund) - Direct Plan - Growth Option
3Y Returns14.85%
HDFC Equity Savings Fund - GROWTH PLAN
3Y Returns11.72%
DSP Equity Savings Fund - Regular Plan - Growth
3Y Returns11.37%
ICICI Prudential Passive Multi-Asset Fund of Funds - Growth
3Y Returns15.83%
Motilal Oswal Asset Allocation FOF- A- Regular Growth
3Y Returns18.08%
Mahindra Manulife Aggressive Hybrid Fund - Regular Plan - Growth
3Y Returns20.15%
HDFC Hybrid Equity Fund - Growth Plan
3Y Returns16.61%